Intercept Pharmaceuticals, Inc.
Oral preparation of obeticholic acid

Last updated:

Abstract:

The present invention pertains to an oral preparation having exceptional elutability, the oral preparation containing obeticholic acid or a pharmacologically acceptable salt thereof, a water-soluble excipient, a disintegrating agent, and a water-soluble polymer binder, wherein the oral preparation is a quick-release tablet.

Status:
Grant
Type:

Utility

Filling date:

30 Mar 2017

Issue date:

16 Aug 2022